Biotechnology Productivity Talent 
Harvard Business
JUNE 4, 2018
” “Our goal,” it stated, “must be to develop the talents of all to their fullest.” The talents of all are not being developed to their fullest, and many U.S. million job openings , which companies are struggling to find the right talent to fill. industries face acute skills shortages.
Harvard Business
SEPTEMBER 21, 2018
Innovation ranks fifth, after more-conventional concerns such as attracting and retaining top talent and the regulatory environment. food, beverage & tobacco, household and personal products); Energy & Utilities (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Management Consulted
MAY 7, 2017
San Francisco, and the Bay Area in general, is famous for its long history of leadership in computing, semiconductors, software, biotechnology, the Internet and other innovation-based industries. It serves industries such as consumer products, healthcare, information & media, life sciences, private equity, and oil & gas.
Harvard Business
NOVEMBER 15, 2016
These policy differences fostered the emergence of a less loyal, more footloose talent pool in Silicon Valley. In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices.
Harvard Business
FEBRUARY 22, 2017
.” When directors evaluated the factors that could limit their company’s ability to achieve its strategic objectives, cybersecurity issues were overshadowed by more salient concerns like attracting and retaining top talent, the regulatory environment, and global competitive threats. Inadequate processes.
Harvard Business
AUGUST 23, 2016
Directors are also consistent in their views of the key challenges to achieving their companies’ strategic objectives: attracting and retaining top talent, the regulatory environment, and domestic competitive threats top the list for directors from both parties. chemicals, metals & mining, paper & forest products).
Tom Spencer
JANUARY 17, 2025
As we stand on the cusp of a political shift in the United States, the intersection of biotechnology, regulatory policy, and healthcare is poised for profound transformation. While there is no explicit move to sever ties with foreign partners, the tone suggests a preference for domestic production and innovation.
Expert insights. Personalized for you.
71 
Let's personalize your content